reported that miR-17 reduced the number of osteoclasts and the production of proinflammatory cytokines by targeting JAK1 and STAT3, thus playing an anti-inflammatory and anti-erosive role in rheumatoid arthritis [38]. The gene discussed is JAK1; the disease is rheumatoid arthritis.